RE: Very Quiet1 Jun 2025 12:16
Having watched the interview the word turnaround for the company stands out along with the private sector insurance and private medical cover is the best income provider.
However found this article
David James, Director of Patient Projects and Influencing at Prostate Cancer Research, said: “The formation of the All-Party Parliamentary Group on Prostate Cancer is a crucial step towards improving early detection and care. With 2025 poised to be a defining year for screening, this APPG will push the UK National Screening Committee and the government to act on much-needed reforms. We’re proud to partner with Prostate Cancer UK and work alongside committed Parliamentarians to drive this vital initiative forward.”
The parliamentary group are meeting again in July and it is very possible that the NHS will eventually become a provider for the Episwitch test especially as they were involved in its research.
The Episwitch test currently is costing £1000 via private medical care and is available via Bupa sites as well as Harley Street clinics.
10 years to develop the test which is a leading test here and across the pond… hopefully the bottom has finally been found as the potential for multi partnership deals is huge…